Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions
Abbott Laboratories (NYSE: ABT) Q1 2023 earnings call dated Apr. 19, 2023 Corporate Participants: Scott Leinenweber -- Vice President, Investor Relations, Licensing and Acquisitions